Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity (NCT06585462)
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 513 in Participants With Obesity
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.
Who can join: Review the eligibility criteria below.
Location: Anaheim Clinical Trials — Anaheim, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (10 Sites)
- Anaheim Clinical Trials — Anaheim, California
- Orange County Research Center — Lake Forest, California
- Fomat Medical Research — Oxnard, California
- Translational Clinical Research LLC — Aventura, Florida
- Clinical Neuroscience Solutions - Jacksonville — Jacksonville, Florida
- New Horizon Research Center — Miami, Florida
- Clinical Pharmacology of Miami, LLC — Miami, Florida
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group — Union City, Georgia
- Lillestol Research LLC — Fargo, North Dakota
- Pinnacle Clinical Research — Austin, Texas
📞 Contact the Study Coordinator
Phone: (866) 572-6436
Email: medinfo@amgen.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiometabolic Disease
Explore by condition: All Cardiometabolic Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.